Xanax Addiction Treatment

Dependence is a physiological process — the body adapts to the presence of Xanax and requires it to function normally. Addiction involves compulsive use despite harmful consequences. 

Someone can be physically dependent on Xanax without being addicted, but dependence does increase the risk of developing addiction — especially with misuse. Both dependence and addiction require medical supervision to safely discontinue Xanax.

You can develop physical dependence on Xanax even when taking it exactly as prescribed, particularly with prolonged use. Physical dependence means your body needs the drug to avoid withdrawal — which is different from the compulsive behavior pattern of addiction. 

If you’re concerned about your relationship with Xanax, even while using it as prescribed, speaking with an addiction specialist is the right step. Our admissions team can help clarify whether what you’re experiencing is dependence, addiction, or both.

Benzodiazepine withdrawal — including Xanax — can cause life-threatening seizures. This risk is highest in people who have been using high doses for extended periods, or who have been combining Xanax with alcohol or other depressants. 

Unlike opioid withdrawal (uncomfortable but rarely fatal), benzodiazepine withdrawal is in the same medical risk category as alcohol withdrawal. Home detox without medical supervision is not safe for most people with Xanax dependence.

A taper schedule is a structured, gradual reduction in Xanax dose — sometimes using a longer-acting benzodiazepine like diazepam to smooth the process. Rather than stopping abruptly, the dose is reduced in small increments over a period of weeks or months depending on the severity of dependence. 

This gives the nervous system time to recalibrate, reducing the severity of withdrawal symptoms and seizure risk. Arista’s addictionologist creates individualized taper protocols based on each client’s clinical history.

Acute withdrawal typically begins within 6–12 hours of the last dose and peaks between 1–4 days. Most acute symptoms resolve within 1–2 weeks with proper medical management. However, 10–25% of long-term users experience protracted withdrawal (PAWS), where anxiety, mood disturbance, cognitive fog, and sleep disruption persist for months — sometimes up to a year. 

This extended phase is manageable with the right clinical support and does not mean recovery is failing.

This is one of the most clinically nuanced challenges in benzodiazepine treatment. Stopping Xanax can trigger intense rebound anxiety that may feel worse than the original condition it was prescribed for. Our clinical team works to differentiate withdrawal-driven anxiety from underlying anxiety disorder, and builds a non-benzodiazepine anxiety management plan using CBT, DBT, mindfulness-based approaches, and when appropriate, non-habit-forming medications. 

The goal is not just sobriety from Xanax — it’s a life with less anxiety than before.

The primary approach is a controlled benzodiazepine taper, often substituting a longer-acting benzo (such as diazepam) for Xanax to allow for smoother dose reduction. Anticonvulsants may be added to reduce seizure risk. 

Our medical team monitors vital signs and withdrawal symptoms throughout, adjusting the protocol as needed. The specific medications used depend on the individual’s clinical picture and are determined by our addictionologist.

Yes. Benzodiazepine detox and addiction treatment is covered by most commercial insurance plans under the Mental Health Parity and Addiction Equity Act. Arista Recovery is in-network with Aetna, BCBS, Cigna, Humana, United Healthcare, and other major carriers. Our admissions team completes a free insurance verification before treatment begins so you know exactly what your coverage includes.

For most people with Xanax dependence, inpatient treatment is the recommended starting point — because medical detox requires 24/7 supervision, and the early days of a benzo taper benefit from constant clinical monitoring. After completing detox and stabilizing in residential treatment, a step-down to outpatient (IOP or PHP) is appropriate for many clients. 

The right path depends on the severity of dependence, co-occurring conditions, and home environment. Our admissions team assesses this before recommending a level of care.

There is no universally safe threshold — overdose risk depends on the individual’s tolerance, whether Xanax is combined with other substances, and their overall health. Xanax alone rarely causes fatal overdose in isolation, but in combination with alcohol, opioids, or other depressants, the risk of respiratory failure rises dramatically. 

The FDA requires a black box warning on Xanax specifically because of the overdose risk when combined with opioids. If you believe someone has overdosed, call 911 immediately.

‍